These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 18336887)

  • 41. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survivin associates with cell proliferation in renal cancer cells: regulation of survivin expression by insulin-like growth factor-1, interferon-gamma and a novel NF-kappaB inhibitor.
    Sato A; Oya M; Ito K; Mizuno R; Horiguchi Y; Umezawa K; Hayakawa M; Murai M
    Int J Oncol; 2006 Apr; 28(4):841-6. PubMed ID: 16525632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells.
    Ni J; Pang ST; Yeh S
    Prostate; 2007 Apr; 67(5):463-71. PubMed ID: 17252538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitors of apoptosis proteins in human cervical cancer.
    Espinosa M; Cantú D; Herrera N; Lopez CM; De la Garza JG; Maldonado V; Melendez-Zajgla J
    BMC Cancer; 2006 Feb; 6():45. PubMed ID: 16504151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells.
    Chen T; Deng C
    Int Immunopharmacol; 2008 Jul; 8(7):1006-11. PubMed ID: 18486912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of PC-1 gene expression on migration ability of prostate cancer cells].
    Zhang H; Wan LC; Wang J; Zhou JG; Huang CF
    Ai Zheng; 2005 Sep; 24(9):1043-7. PubMed ID: 16159422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason score.
    Liu W; Gong J; Hu J; Hu T; Sun Y; Du J; Sun C; Guan M; Jiang H; Lu Y
    Urology; 2011 Apr; 77(4):1006.e1-7. PubMed ID: 21310466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
    Soulitzis N; Karyotis I; Delakas D; Spandidos DA
    Int J Oncol; 2006 Aug; 29(2):305-14. PubMed ID: 16820871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance].
    Liu BQ; Wu YD; Wei JX; Zhang T; Liu RL; Ma TX
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):997-1001. PubMed ID: 18077911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
    Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
    Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.
    Taubert H; Kappler M; Bache M; Bartel F; Köhler T; Lautenschläger C; Blümke K; Würl P; Schmidt H; Meye A; Hauptmann S
    Oncogene; 2005 Aug; 24(33):5258-61. PubMed ID: 15856009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of knockdown of wild-type survivin, survivin-2B or survivin-delta3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditions.
    Kappler M; Rot S; Taubert H; Greither T; Bartel F; Dellas K; Hänsgen G; Trott KR; Bache M
    Cancer Gene Ther; 2007 Dec; 14(12):994-1001. PubMed ID: 17885676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
    Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
    Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies.
    Caldas H; Honsey LE; Altura RA
    Mol Cancer; 2005 Mar; 4(1):11. PubMed ID: 15743529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topotecan and small interfering RNA suppress survivin expression synergistically in Caki-1 renal cancer cells: Direct suppression of survivin and enhancement of transfection efficiency by topotecan.
    Sato A; Ito K; Asano T; Sumitomo M; Asano T; Hayakawa M
    Int J Oncol; 2008 Jan; 32(1):171-6. PubMed ID: 18097556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human telomerase reverse transcriptase expression correlates with vascular endothelial growth factor-promoted tumor cell proliferation in prostate cancer.
    Tang J; Wang Z; Li X; Li J; Shi H
    Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(2):83-93. PubMed ID: 18437586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of growth hormone receptors in human prostate cancer cell lines.
    Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
    Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Expression and clinical significance of antiapoptosis gene XIAP in prostate cancer].
    Liu J; Li M; Xia S
    Zhonghua Nan Ke Xue; 2004 Nov; 10(11):832-5. PubMed ID: 15595685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.